KLK3 and prostate carcinoma: Biochemical recurrence (BCR), defined as a re-increase in prostate-specific antigen (PSA) above 0.2 μg/L and confirmed by two consecutive elevated values, is a decisive risk factor for distant metastasis, prostate cancer-specific and overall mortality 35, 36.